These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10860353)

  • 21. Bone pain palliation with 85Sr therapy.
    Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platinum compounds as radiosensitizers in strontium-89 metabolic radiotherapy.
    Sciuto R; Festa A; Tofani A; Pasqualoni R; Semprebene A; Cucchi R; Ferraironi A; Rea S; Maini CL
    Clin Ter; 1998; 149(921):43-7. PubMed ID: 9621488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A direct measurement of strontium-89 activity in bone metastases.
    Ben-Josef E; Maughan RL; Vasan S; Porter AT
    Nucl Med Commun; 1995 Jun; 16(6):452-6. PubMed ID: 7675358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of patients after therapy with unsealed radionuclides.
    International Commission on Radiological Protection
    Ann ICRP; 2004; 34(2):v-vi, 1-79. PubMed ID: 15571759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Optimal control of waste water contaminated with radionuclides].
    Egorov VN
    Gig Sanit; 1991 Mar; (3):52-4. PubMed ID: 1885018
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of strontium-89 in the analgesic treatment of bone metastases].
    Hayek D; Ritschard J; Zwahlen A; Courvoisier B; Donath A
    Schweiz Med Wochenschr; 1980 Aug; 110(31-32):1154-9. PubMed ID: 7444409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of the radioactive strontium (89Sr) chloride agent, SMS.2P for pain palliation in patients with metastatic bone tumor in phase III multicenter clinical trial].
    Kimura Y; Hamamoto K; Furudate M; Fukuda H; Shishido F; Endo K; Yui N; Kusakabe K; Suzuki K; Kawakami K; Ishii K; Koizumi K; Yokoyama K; Hisada K; Nakagawa T; Kasagi K; Konishi J; Ichiya Y; Masuda K; Nakajo M; Kubo A; Torizuka K
    Kaku Igaku; 1996 Dec; 33(12):1347-58. PubMed ID: 9023442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.
    Sciuto R; Festa A; Rea S; Pasqualoni R; Bergomi S; Petrilli G; Maini CL
    J Nucl Med; 2002 Jan; 43(1):79-86. PubMed ID: 11801708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy.
    Malmberg I; Persson U; Ask A; Tennvall J; Abrahamsson PA
    Urology; 1997 Nov; 50(5):747-53. PubMed ID: 9372886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nuclear medicine therapy of bone metastases].
    Kimmig B; Hermann HJ; Kober B
    Rontgenblatter; 1983 Jul; 36(7):216-9. PubMed ID: 6622951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 90Sr, 137Cs and (239,240)Pu concentration surface water time series in the Pacific and Indian Oceans--WOMARS results.
    Povinec PP; Aarkrog A; Buesseler KO; Delfanti R; Hirose K; Hong GH; Ito T; Livingston HD; Nies H; Noshkin VE; Shima S; Togawa O
    J Environ Radioact; 2005; 81(1):63-87. PubMed ID: 15748662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
    Flamm J; Burkert S
    Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective use of strontium-89 in osseous metastases.
    Kuroda I
    Ann Nucl Med; 2012 Apr; 26(3):197-206. PubMed ID: 22160737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum PICP as a bone formation marker in 89Sr and external beam radiotherapy of prostatic bony metastases.
    Papatheofanis FJ
    Br J Radiol; 1997 Jun; 70(834):594-8. PubMed ID: 9227252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radionuclide contamination of sediment deposits in the Ob and Yenisey estuaries and areas of the Kara Sea.
    Standring WJ; Stepanets O; Brown JE; Dowdall M; Borisov A; Nikitin A
    J Environ Radioact; 2008 Apr; 99(4):665-79. PubMed ID: 17976877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of actual condition of management and disposal of medical radioactive waste in Korea].
    Watanabe H; Nagaoka H; Yamaguchi I; Horiuchi S; Imoto A
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2009 Jul; 65(7):952-7. PubMed ID: 19661730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of bone scintigraphy to select patients with multiple myeloma for treatment with strontium-89.
    Edwards GK; Santoro J; Taylor A
    J Nucl Med; 1994 Dec; 35(12):1992-3. PubMed ID: 7989983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Imaging of strontium-89 uptake with bremsstrahlung using NaI scintillation camera].
    Narita H; Uchiyama M; Ooshita T; Hirase K; Makino M; Mori Y; Sekine H; Kawakami K
    Kaku Igaku; 1996 Nov; 33(11):1207-12. PubMed ID: 8986059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strontium-89 therapy for painful osseous metastatic prostate and breast cancer.
    Hansen DV; Holmes ER; Catton G; Thorne DA; Chadwick DH; Schmutz DA
    Am Fam Physician; 1993 Jun; 47(8):1795-800. PubMed ID: 7684554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary application of strontium-89 for the treatment of bone metastases from prostate cancer].
    Zhao W; Deng H; Jie P; Qing C; Zhang X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1251-4. PubMed ID: 21374974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.